Loading stock…

Alignment Healthcare, Inc. (ALHC) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Alignment Healthcare, Inc.

ALHCMarket cap $1.77BPrice $8.6

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Runs Medicare Advantage plans built around a tech platform that flags health risks before they become ER visits. Growing faster than nearly every insurer in the space by betting on seniors, not shareholders, first.

In Bastion Portfolios?

52W Return-50%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+40%10

Revenue Forecast

Rev CAGR (1y)+32%9

Rev CAGR (3y)+27%10

Rev CAGR (5y)+27%10

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+39%9

EPS Growth Y+3+46%9

Quality

Margins

EBIT Margin1%2

Net Income Margin1%2

Free Cash Flow Margin4%4

Debt

Net Debt/EBITDA-4.010

Efficiency

ROE20%8

ROA4%5

Earnings Stability22

GEAR+STRONG76

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)137

P/E Ratio (Forward 3y)89

P/BV6.72

EV Multiples

EV/EBITDA Fwd97

EV/EBIT Fwd118

Yield

Free Cash Flow Yield10.0%9

Dividend Yieldna–

Momentum

Short term

1 month return-36%1

3 month return-57%1

YTD return-57%1

Mid term

Price vs 52wHigh34%1

1 year return-52%1

Long term

3 year return+17%4

5 year return-51%1

Risk Shield

Price Risk

Beta0.67

Volatility69%2

Free Cash Flow

Free Cash Flow Margin4%4

Free Cash Flow Yield10.0%9

Quality

ROCE10%6

Earnings Stability22

Net Debt/EBITDA-4.010

02Growth

Is it actually growing, and how fast?

ALHCAlignment Healthcare

Revenue FY25$3.9B

GROWTH RATING↗

VERY STRONG97 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+40%10

Revenue, next 1Y+32%9

Revenue, next 3Y, CAGR+27%10

Revenue, next 5Y, CAGR+27%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+39%9

EPS growth, FY28E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 97% of companies worldwide.

Revenue grew 40%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 27%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 27%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 39%/yr vs revenue 27%/yr), so margins should widen.

WATCH

Revenue grew 40%/yr over the last 3 years; forecasts see it cooling to 27%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK2 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-36%1

3-month return-57%1

YTD return-57%1

MID & LONG-TERM▾SCORE

% of 52-week high34%1

1-year return-52%1

3-year return+17%4

5-year return-51%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+17% over three years and -51% over five), behind 70% of the market.

It's down 52% over the past year, now 66% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-36%), over three months (-57%) and so far this year (-57%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Alignment Healthcare, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ALHCAlignment Healthcare

Revenue FY25$3.9B

GROWTH RATING↗

VERY STRONG97 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+40%10

Revenue, next 1Y+32%9

Revenue, next 3Y, CAGR+27%10

Revenue, next 5Y, CAGR+27%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+39%9

EPS growth, FY28E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 97% of companies worldwide.

Revenue grew 40%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 27%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 27%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 39%/yr vs revenue 27%/yr), so margins should widen.

WATCH

Revenue grew 40%/yr over the last 3 years; forecasts see it cooling to 27%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK2 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-36%1

3-month return-57%1

YTD return-57%1

MID & LONG-TERM▾SCORE

% of 52-week high34%1

1-year return-52%1

3-year return+17%4

5-year return-51%1

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+17% over three years and -51% over five), behind 70% of the market.

It's down 52% over the past year, now 66% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-36%), over three months (-57%) and so far this year (-57%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Alignment Healthcare, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community